Case of possible encephalopathy following receiving the first dose of Iranian COVID‐19Vaccine; COVIran Barakat
Abstract We report a case of possible encephalopathy after receiving the first dose of Iran's COVIran Barekat vaccine. The patient had no history of neurological or mental illness. Clinical examinations and radiology reports were performed and differential diagnoses were analyzed by the treatme...
Main Authors: | Mohammad Javad Fallahi, Navid Esmaeilzadeh Shahri, Zohre Khodamoradi, Moazameh Meymandi Nia, Faezeh Sehatpour, Laleh Mahmoudi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.5661 |
Similar Items
-
Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system
by: Mostafa Enayatrad, et al.
Published: (2023-03-01) -
Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines: A Prospective Cohort Study
by: Zahra Zare, et al.
Published: (2022-12-01) -
Unmasking sarcoidosis following SARS‐CoV‐2 vaccination: A case report
by: Fatemeh Mohaghegh, et al.
Published: (2022-12-01) -
Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis
by: Mahsa Khodadoostan, et al.
Published: (2018-10-01) -
Encephalopathy caused by disulfiram
by: R. Sant’Angelo, et al.
Published: (2021-04-01)